DJIA 16,424.85 162.29 1.00%
NASDAQ 4,086.23 0.00 0.00%
S&P 500 1,862.31 19.33 1.05%
market minute promo


company name or ticker
Company Photos
(Click to zoom)

Dr. Reddy's Laboratories Ltd (RDY) Ex-Dividend Date Scheduled for July 10, 2013

5 Stocks Pushing The Drugs Industry Lower

Dr. Reddy's Launches Generic Lamictal XR - Analyst Blog

Mylan Inks Deal - Analyst Blog

Cheap Indian Drugs Spur Rare Congressional Bipartisanship

Congress and Big Pharma team up to stop India from selling cheap generic drugs to its citizens.

Dr. Reddy's Launches Generic Lamictal

Treatment for epilepsy and bipolar disorder had over $300 million in sales in the last 12 months.

A Peek Into The Market Before The Trading Starts

Dr. Reddy's Launches Generic Version of Lamictalets XR in US

Dr. Reddy’s Announces the Launch of Lamotrigine Extended-Release Tablets

Research Abstracts, Phase 2 Results, and Market Availability of Formulations and Treatments- Researc

Research Abstracts, Phase 2 Results, and Market Availability of Formulations and Treatments- Research Report on Teva, Forest, Pharmacyclics, Cubist, and Dr. Reddy's